In those with presenilin 1 (PS1) mutation, amyloid precursor protein (APP) mutation, and ApoE4 allele(s), AD genetic risk factors known to affect Aβ processing, cerebral glucose hypometabolism is present prior to AD symptoms [12,13,101]. The gene discussed is APOE; the disease is Alzheimer disease.